Get started
Author

Ottavia D’Oria

Observed names: D'Oria, Ottavia, D'oria, Ottavia, D’Oria, Ottavia, O. D'Oria, O. D’Oria, O., D'Oria, Ottavia D'''''Oria, Ottavia D'Oria, Ottavia D'oria, Ottavia D’ORIA, Ottavia D’oria
Observed institutions: Università Campus Bio-Medico, Policlinico Umberto I, Azienda Ospedaliera San Camillo-Forlanini, Ospedale Veris Delli Ponti Scorrano, Azienda Ospedaliera Sant'Andrea, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Carlo Forlanini Hospital, Sapienza University of Rome, University of Palermo
ORCID: 0000-0002-3482-1523
Observed ORCID: 0000-0002-3482-1523
OpenAlex ID: A5064921812
Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives
2023 · Tullio Golia D'Augè, Andrea Giannini, et al. · Clinical and Experimental Obstetrics & Gynecology · 99
PDF
New Advances in Cervical Cancer: From Bench to Bedside
2022 · Ottavia D’Oria, Giacomo Corrado, et al. · International Journal of Environmental Research and Public Health · 90
PDF
Outcomes of High-Grade Cervical Dysplasia with Positive Margins and HPV Persistence after Cervical Conization
2023 · Andrea Giannini, Violante Di Donato, et al. · Vaccines · 78
Preoperative frailty assessment in patients undergoing gynecologic oncology surgery: A systematic review
2021 · Violante Di Donato, Giuseppe Caruso, et al. · Gynecologic Oncology · 75
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
2023 · Andrea Giannini, Camilla Di Dio, et al. · American Journal of Clinical Oncology · 71
Radiomics and Molecular Classification in Endometrial Cancer (The ROME Study): A Step Forward to a Simplified Precision Medicine
2022 · Giorgio Bogani, Valentina Chiappa, et al. · Healthcare · 67
PDF
Age-Adjusted Charlson Comorbidity Index Predicts Survival in Endometrial Cancer Patients
2022 · Violante Di Donato, Ottavia D’Oria, et al. · Gynecologic and Obstetric Investigation · 63
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part II: Evaluation of tolerability and safety
2018 · Violante Di Donato, Michele Carlo Schiavi, et al. · Maturitas · 63
Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and Perspectives
2023 · Ilaria Cuccu, Ottavia D’Oria, et al. · Healthcare · 62
PDF
Radical Hysterectomy for Early Stage Cervical Cancer
2022 · Giorgio Bogani, Violante Di Donato, et al. · International Journal of Environmental Research and Public Health · 62
PDF
Fractional Co2 laser for vulvo-vaginal atrophy in gynecologic cancer patients: A valid therapeutic choice? A systematic review
2022 · Ottavia D'Oria, Andrea Giannini, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 61
Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature
2023 · Ottavia D’Oria, Giorgio Bogani, et al. · Expert Opinion on Pharmacotherapy · 59
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer
2022 · Giorgio Bogani, Violante Di Donato, et al. · Gynecologic Oncology · 59
PDF
Modified fragility index and surgical complexity score are able to predict postoperative morbidity and mortality after cytoreductive surgery for advanced ovarian cancer
2020 · Violante Di Donato, Anna Di Pinto, et al. · Gynecologic Oncology · 59
Therapeutic vaccines and immune checkpoints inhibition options for gynecological cancers
2018 · Chiara Di Tucci, Michele Carlo Schiavi, et al. · Critical Reviews in Oncology/Hematology · 58
Hysterectomy Using Vaginal Natural Orifice Transluminal Endoscopic Surgery Compared with Classic Laparoscopic Hysterectomy: A New Advantageous Approach? A Systematic Review on Surgical Outcomes
2023 · Christian Chaccour, Andrea Giannini, et al. · Gynecologic and Obstetric Investigation · 57
Hepatobiliary Disease Resection in Patients with Advanced Epithelial Ovarian Cancer: Prognostic Role and Optimal Cytoreduction
2020 · Violante Di Donato, Andrea Giannini, et al. · Annals of Surgical Oncology · 54
PDF
Safety evaluation of fractional CO2 laser treatment in post-menopausal women with vaginal atrophy: A prospective observational study
2020 · Violante Di Donato, Ottavia D’Oria, et al. · Maturitas · 53
The great debate: Surgical outcomes of laparoscopic versus laparotomic myomectomy. A meta-analysis to critically evaluate current evidence and look over the horizon
2024 · Andrea Giannini, Ilaria Cuccu, et al. · European Journal of Obstetrics & Gynecology and Reproductive Biology · 52
PDF
The giant steps in surgical downsizing toward a personalized treatment of vulvar cancer
2021 · Andrea Giannini, Ottavia D'Oria, et al. · Journal of obstetrics and gynaecology research · 51
PDF
Ospemifene for the treatment of vulvar and vaginal atrophy: A meta-analysis of randomized trials. Part I: Evaluation of efficacy
2018 · Violante Di Donato, Michele Carlo schiavi, et al. · Maturitas · 51
The role of preoperative frailty assessment in patients affected by gynecological cancer: a narrative review
2022 · O. D’Oria, T. Golia D’Auge, et al. · Italian Journal of Gynaecology and Obstetrics · 50
PDF
The role of L1CAM as predictor of poor prognosis in stage I endometrial cancer: a systematic review and meta-analysis
2023 · Andrea Giannini, Ottavia D’Oria, et al. · Archives of Gynecology and Obstetrics · 49
Advances on Prevention and Screening of Gynecologic Tumors: Are We Stepping Forward?
2022 · Andrea Giannini, Giorgio Bogani, et al. · Healthcare · 49
PDF
State of the art on HPV-related cervical lesions
2024 · T. Golia D’Augè, I. Cuccu, et al. · Italian Journal of Gynaecology and Obstetrics · 48
PDF
Works count: 79
Citation count: 2,369
H-index: 34
I10-index: 52
Year
Topic
Type